Katharina Zetterström1, Marjan Vaez2, Kristina Alexanderson2, Torbjörn Ivert3, Kenneth Pehrsson4, Niklas Hammar5, Margaretha Voss6. 1. Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden katharina.zetterstrom@ki.se. 2. Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. 3. Department of Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. 4. Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. 5. AstraZeneca R&D, Mölndal, Sweden Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. 6. Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Department of Analysis and Forecasts, Swedish Social Insurance Agency, Stockholm, Sweden.
Authors: Mo Wang; Marjan Vaez; Thomas Ernst Dorner; Syed Ghulam Rahman; Magnus Helgesson; Torbjörn Ivert; Ellenor Mittendorfer-Rutz Journal: BMJ Open Date: 2019-12-18 Impact factor: 2.692